Mineralys Therapeutics
Marcela Bravo is an experienced program management professional currently serving as Associate Director at Mineralys Therapeutics, Inc., since August 2023, following a tenure as Senior Manager in the same department. Previously, Marcela held roles at RemeGen Biosciences, where responsibilities included serving as Sr. Clinical Project Manager and Clinical Project Manager from April 2021 to August 2023. Prior experience includes positions at REGENXBIO Inc. as an Associate Clinical Project Manager, Sarah Cannon Research Institute as Clinical Research Associate II, and Wright Medical in various clinical research roles. Marcela's expertise encompasses clinical monitoring, site management, document preparation and review, statistical analysis of study data, and financial tracking for clinical studies. Academic qualifications include a Master’s Degree in Bioinformatics and Computational Biology from the University of Minnesota and a Bachelor’s Degree in Biochemistry from the University of Nebraska-Lincoln.
This person is not in any teams
This person is not in any offices
Mineralys Therapeutics
2 followers
At Mineralys Therapeutics, they aim to redefine hypertension diagnosis, management, and treatment. They are driven to break the “trial and failure” approach to hypertension management and bring a personalized approach to the management of hypertension.